C Adamy
Overview
Explore the profile of C Adamy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adamy C, Le Corvoisier P, Candiani G, Kirsch M, Pavoine C, Defer N, et al.
Arch Mal Coeur Vaiss
. 2005 Oct;
98(9):906-12.
PMID: 16231578
The pro-inflammatory cytokine, tumor necrosis factor alpha (TNF alpha), in concert with neurohormones, contributes to chronic heart failure (CHF) progression. This implies that TNF a antagonism may constitute an important...
2.
Oliviero P, Chassagne C, Kolar F, Adamy C, Marotte F, Samuel J, et al.
J Mol Cell Cardiol
. 2000 Sep;
32(9):1631-45.
PMID: 10966826
The development of cardiac hypertrophy during neonatal life and in adults implies different processes. The angiotensin II (Ang II) system is involved in the development of cardiac hypertrophy in adults,...
3.
Chassagne C, Eddahibi S, Adamy C, Rideau D, Marotte F, Dubois-Rande J, et al.
Am J Respir Cell Mol Biol
. 2000 Mar;
22(3):323-32.
PMID: 10696069
Lung vessel muscularization during hypoxic pulmonary hypertension is associated with local renin-angiotensin system activation. The expression of angiotensin II (Ang II) AT1 and AT2 receptors in this setting is not...
4.
Rouis M, Adamy C, Duverger N, Lesnik P, Horellou P, Moreau M, et al.
Circulation
. 1999 Aug;
100(5):533-40.
PMID: 10430768
Background: To define the role of metalloproteinases (MMPs) in the development of lipid-rich atherosclerotic lesions in relation to the balance between proteolytic and antiproteolytic activities, we investigated the impact of...